Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
- PMID: 37547783
- PMCID: PMC10397530
- DOI: 10.18502/jfrh.v17i2.12869
Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
Abstract
Objective: Comparison of two different intervals of misoprostol administration after mifepristone in second trimester abortions.
Materials and methods: This 12-month prospective study was conducted at a tertiary care facility. Only pregnancies with congenital deformity or sterilisation failure were included in the study's recruitment of 100 women who visited the hospital for a second trimester abortion between 12 and 20 weeks; cases with scarred uteri were omitted. In a systematic random selection of 50 women in each group, the administration of 200 mg of mifepristone orally was followed by two distinct intervals of intravaginal misoprostol administration at 24- and 48-hour intervals. After 24 hours, group A women received intravaginal 400 mcg misoprostol three hourly, up to a maximum of five doses, while group B received the same doses after 48 hours. Induction abortion interval noted on various parameters and paired t test and chi square test applied.
Results: The mean IAI following misoprostol administration was 8.14 2±.03 hours in group A and 7.71 ±2.56 hours in group B. This difference was statistically insignificant. Average misoprostol doses for group A were 1.68±0.71 and for the group, B were 1.68±0.84; both doses were found to be statistically insignificant when used to induce abortion. All women aborted successfully in each group. There was no significant difference in side effects in both groups.
Conclusion: Based on the results it was observed that shorter interval between mifepristone and misoprostol i.e., 24 hours can be chosen to decrease the hospital stay as there was no significant difference was seen after intravaginal misoprostol in terms of induction abortion interval, number of doses and side effects.
Keywords: Mifepristone; Misoprostol; Second Trimester Abortion.
Copyright © 2023 Tehran University of Medical Sciences. Published by Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of Interests Authors declare no conflict of interests.
Figures
Similar articles
-
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).Hum Reprod. 1993 Oct;8(10):1744-6. doi: 10.1093/oxfordjournals.humrep.a137927. Hum Reprod. 1993. PMID: 8300840 Clinical Trial.
-
Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.Contraception. 1996 May;53(5):281-3. Contraception. 1996. PMID: 8724617 Clinical Trial.
-
Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.Br J Obstet Gynaecol. 1999 Jul;106(7):706-10. doi: 10.1111/j.1471-0528.1999.tb08371.x. Br J Obstet Gynaecol. 1999. PMID: 10428528
-
Update on second trimester medical abortion.Curr Opin Obstet Gynecol. 2017 Dec;29(6):413-418. doi: 10.1097/GCO.0000000000000409. Curr Opin Obstet Gynecol. 2017. PMID: 28922193 Review.
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
Cited by
-
Risk Factors for Failure of Second-Trimester Termination with Misoprostol as a Single Agent.J Clin Med. 2024 Sep 9;13(17):5332. doi: 10.3390/jcm13175332. J Clin Med. 2024. PMID: 39274544 Free PMC article.
References
-
- Gemzell-Danielsson K, Lalitkumar S. Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management. Reprod Health Matters. 2008; 16:162–172. - PubMed
-
- Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update. 2007; 13:37–52. - PubMed
-
- Cooper DB, Menefee GW. Dilatation and Curettage. StatPearls Publishing; 2022. - PubMed
-
- Grimes DA. The Choice of Second Trimester Abortion Method: Evolution, Evidence and Ethics. Reprod Health Matters. 2008; 16:183–188. - PubMed
-
- Tang OS, Ho PC. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol. 2002; 16:237–246. - PubMed
LinkOut - more resources
Full Text Sources